Loading...
Evaluating outcomes of mother–infant pairs using dolutegravir for HIV treatment during pregnancy
OBJECTIVES: Dolutegravir (DTG), a second-generation integrase inhibitor, is an effective treatment for HIV but its safety and efficacy are not well established in pregnancy. Here, we assess maternal and infant outcomes of mother–infant pairs using DTG-containing regimens during pregnancy. METHODS: W...
Na minha lista:
| Udgivet i: | AIDS |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6125741/ https://ncbi.nlm.nih.gov/pubmed/29944472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001931 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|